摘要
目的评价自制可视穿刺针结合输尿管通道鞘治疗肾结石的临床意义。方法回顾性分析2016年6月至2017年2月8例用自制可视穿刺针结合输尿管通道鞘治疗肾结石患者的临床资料。结果 8例均留置输尿管通道鞘和穿刺成功。除1例因结石移位需输尿管软镜辅助治疗外,均成功直视下碎石。结石大小为(21.9±7.3)mm、手术时间(43.6±13.6)min、术后第1天疼痛VAS评分(2.8±1.3)分、术后血红蛋白减少7.0 g/L[(143.1±12.2)g/L vs.(136.1±10.5)g/L,P>0.05]、住院时间(3.1±1.0)d。无输血患者。术后1个月无石率为87.5%(7/8),1例残留结石直径约3 mm,术后随访3个月后结石消失,术后3个月无石率为100%(8/8)。结论自制可视穿刺针结合输尿管通道鞘治疗肾结石是可行的,有利于提高术后无石率,减少PCNL相关并发症。
Objective To evaluate the clinical value of a new optic puncture needle designed by our department for renal calculi treatment. Methods There were 8 patients undergoing micro-PCNL with the new device from June 2016 to February 2017. Values of basic demographic data, operation time, pain score, drop in hemoglobin and complications were recorded. Results The mean stone size, operation time, pain score, drop in hemoglobin, and in-hospital time was （21.9 ±7.3） mm, （43.6 ±13.6） min, 2.8 ± 1.3, 7.0 g/LE （ 133.2±10.3 g/L vs. （ 123.2 ± 13.9） g/L, P 〉 0.05] and （3.1 ± 1.0）d, respectively. No patient required blood transfusion. Stone-free rate at 1 and 3 months post-operation were 87.5% （7/8） and 100 % （8/8）, respectively. One suffered urinary tract infections （ Clavien I ） and was treated with antibiotics. There were no major complications. Conclusion The new device for treatment of renal calculi is feasible and effective.
出处
《实用医学杂志》
CAS
北大核心
2017年第17期2896-2899,共4页
The Journal of Practical Medicine
